BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Stock

Certificat

FC97S

DE000SW26AP4

Market Closed - Euronext Paris 11:59:29 2024-05-13 am EDT
4.398 EUR +5.01% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month+18.38%
1 month+2.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-13 4.398 +5.01% 98
24-05-10 4.188 +4.91% 102
24-05-09 3.992 +2.12% 104
24-05-08 3.909 +1.59% 103
24-05-07 3.848 +7.70% 101

Real-time Euronext Paris

Last update May 13, 2024 at 11:59 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
FC97S
ISINDE000SW26AP4
Date issued 2023-09-07
Strike 183.6 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 7.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.6
Lowest since issue 3.057

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
227.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+22.65%
Consensus
  1. Stock Market
  2. Certificates
  3. FC97S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW